Atlas FDA

SPOT-LIGHT HER2 CISH KIT

FDA premarket approval P050040/S003 · decided 2012-07-06

Approval details

PMA number
P050040
Supplement
S003
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SPOT-LIGHT HER2 CISH KIT
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Applicant
Invitrogen Corporation
Date received
2012-06-01
Decision date
2012-07-06
Days to decision
35 days
Decision code
OK30
Product code
NYQ
Advisory committee
Pathology
Expedited review
No
Location
Grand Island, NY
Statement
EXTENSION OF THE EXPIRATION DATE FOR A SINGLE LOT OF HER-2 SPT DNA TEMPLATE (LOT 63013).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
AIM-V (R) MEDIUM, MODEL 087-0112 (K022086)Invitrogen Corporation2002-12-23